PCBP2 in gastrointestinal cancers: fundamental mechanism and clinical potential

Chenyang Wang1,2, Xi Chen1,2, Lili Duan1,2

  • 1Department of Digestive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, China.

Journal of Molecular Medicine (Berlin, Germany)
|June 7, 2025
PubMed

Insights

Poly(rC)-Binding Protein 2 (PCBP2) is crucial in cancer development and progression. Understanding PCBP2 in gastrointestinal cancers offers new diagnostic and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Poly(rC)-Binding Protein 2 (PCBP2) is a key regulator of gene expression.
  • PCBP2 expression is implicated in various solid tumors.
  • Its role in gastrointestinal cancers is an area of active research.

Purpose of the Study:

  • To review the literature on PCBP2 expression and function in cancer.
  • To focus on the role of PCBP2 in gastrointestinal malignancies.
  • To explore PCBP2's clinical utility in diagnosis, therapy, and prognosis.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of PCBP2 expression patterns in gastrointestinal cancers.
  • Examination of molecular pathways involving PCBP2 in oncogenesis.

Main Results:

  • PCBP2 plays a significant role in the development and progression of gastrointestinal cancers.
  • Specific molecular pathways influenced by PCBP2 in cancer have been identified.
  • Evidence suggests PCBP2's involvement in both transcriptional and post-transcriptional regulation relevant to cancer.

Conclusions:

  • PCBP2 is a critical factor in gastrointestinal cancer.
  • Targeting PCBP2 presents potential for novel diagnostic and therapeutic approaches.
  • Further research into PCBP2's mechanisms can advance gastrointestinal oncology.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K